Tag: European Medicines Agency
September 3, 2019
Aridis Tumbles After Phase 2 Trial Fails to Meet Endpoint
Aridis Pharmaceuticals dipped more than 6 percent on the news that AR-105 did not meet its primary endpoint in a... July 23, 2019
Cytokinetics Granted European Orphan Designation for Reldesemtiv to Treat Spinal Musclar Atrophy
Cytokinetics (NASDAQ:CYTK) has announced that the European Medicines Agency (EMA) has granted the company orphan medicinal product designation to reldesemtiv... January 16, 2019
Aeterna Zentaris Receives European Marketing Clearance for Macimorelin
Aeterna Zentaris (NASDAQ:AEZS;TSX:AEZS) announced that the European Medicines Agency (EMA) has granted marketing authorization for macimorelin, an orally available ghrelin agonist,... January 15, 2019
European Medicines Agency validates Oasmia Pharmaceutical AB’s application to add efficacy data to the approved Apealea
Oasmia Pharmaceutical AB (NASDAQ:OASM) AB today announce that the European Medicines Agency (EMA) has validated a type II variation application... December 4, 2018
Scholar Rock Announces Positive Opinion by the European Medicines Agency
Scholar Rock (NASDAQ:SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play... October 19, 2018
Shire: CHMP Recommends EU Marketing Authorisation of lanadelumab for the Prevention of HAE Attacks
Shire (LSE:SHP, NASDAQ:SHPG), the leading global biotechnology company focused on rare diseases, announced today that the European Medicines Agency’s (EMA)... September 14, 2018